Advocacy intelligence hub — real-time data for patient organizations
Hoag Memorial Hospital Presbyterian — PHASE2
Mayo Clinic — NA
Hospital Clinic of Barcelona
City of Hope Medical Center — NA
Oslo University Hospital — NA
Changhai Hospital
Dana-Farber Cancer Institute — NA
Dana-Farber Cancer Institute
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs
Open now
Patient Assistance Programs1
Bizengri
Partner Therapeutics, Inc.
Onivyde
(irinotecan liposome injection)Orphan drugIpsen Biopharmaceuticals, Inc.
12.1 Mechanism of Action Irinotecan liposome injection is a topoisomerase 1 inhibitor encapsulated in a lipid bilayer vesicle or liposome. Topoisomera...
Michael Goggins, MD, MB BCh BAO
Johns Hopkins University
📍 PHILADELPHIA, PA
Shounak Majumder, M.D.
The Mayo Clinic
📍 ROCHESTER, MN
Kim E. Nichols, MD
St. Jude Children's Research Hospital
📍 Memphis, Tennessee
Wendy K Chung, MD
Columbia University
Josh F Peterson, MD, MPH
Vanderbilt University Medical Center
Shaffer Mok, MD, MBS
Moffitt Cancer Center
📍 TAMPA, FL